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Abstract
Background Due to significant medical improve-
ments, persons with Down syndrome now live well
into adulthood. Consequently, primary care for
adults with Down syndrome needs to incorporate
routine care with screening for condition-specific
comorbidities. This study seeks to evaluate the
adherence of primary care physicians to age- and
condition-specific preventive care in a cohort of
adults with Down syndrome.
Methods In this retrospective observational cohort
study, preventive screening was evaluated in patients
with Down syndrome aged 18–45 years who
received primary care in an academic medical
centre from 2000 to 2008. Comparisons were made
based on the field of patients’ primary care provid-
ers (Family or Internal Medicine).
Results This cohort included 62 patients, median
index age = 33 years. Forty per cent of patients
received primary care by Family Physicians, with
60% seen by Internal Medicine practices. Patient
demographics, comorbidities and overall screening
patterns were similar between provider groups.
Despite near universal screening for obesity and
hypothyroidism, adherence to preventive care
recommendations was otherwise inconsistent.
Screening was ‘moderate’ (50–80%) for cardiac
anomalies, reproductive health, dentition, and the
combined measure of behaviour, psychological, or
memory abnormalities. Less than 50% of patients
were evaluated for obstructive sleep apnea, atlanto-
axial instability, hearing loss or vision loss.
Conclusions We observed inconsistent preventive
care in adults with Down syndrome over this 8.5-
year study. This is concerning, given that the
adverse effects of many of these conditions can
be ameliorated if discovered in a timely fashion.
Further studies must evaluate the implications of
screening practices and more timely identification
of comorbidities on clinical outcomes.
Keywords adult, Down syndrome, preventive care,
primary care
Introduction
Down syndrome is among the most commonly
identifiable causes of developmental delay, occur-
ring in an estimated 14.5 per 10 000 live births
(Parker et al. 2010). Largely due to improvements in
early medical interventions, increasing numbers of
persons with Down syndrome now survive well into
adulthood (American Academy of Pediatrics 1996).
Nearly 80% survive into adolescence (Hayes et al.
1997), with an average life expectancy of nearly 60
years (Glasson et al. 2002).
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Individuals with Down syndrome are at increased
risk of developing multiple comorbidities which
require regular care by both specialists and primary
care physicians. Conditions such as intellectual dis-
ability (ID), congenital heart disease, haematologic
abnormalities, gastrointestinal atresia, obstructive
sleep apnea, and hearing and vision abnormalities
are well described in children with Down syndrome
(Cooley & Graham 1991; Baum et al. 2008; Bull &
the Committee on Genetics 2011). However, the
onset of many of these comorbidities is not isolated
to early childhood. In addition to conditions that
typically accompany the ageing process, adults with
Down syndrome can also develop medical condi-
tions directly related to their underlying genetic
abnormality. This includes increased incidence of
conditions commonly associated with Down syn-
drome (e.g. hypothyroidism, obesity, and obstruc-
tive sleep apnea) (Rubin & Crocker 1989; Cooley &
Graham 1991; American Academy of Pediatrics
2001; Roizen 2002; NewYork Commissioner’s Task
Force 2009; Rimmer et al. 2011; Steingass et al.
2011), as well as the development of new comor-
bidities, such as cardiac valvular abnormalities,
‘accelerated aging’, and ‘early senescence’ (Gold-
haber et al. 1986, 1987; Rubin & Crocker 1989;
Geggel et al. 1993; Pueschel et al. 1995; Cohen
1999; Smith 2001; Bittles et al. 2007; NewYork
Commissioner’s Task Force 2009; Steingass et al.
2011).
Given the rising incidence and prevalence of
medical comorbidities in adults with Down syn-
drome, there is a tremendous need for preventive
screening in this population.The adverse effects of
many of these conditions can be ameliorated if dis-
covered and treated in a timely fashion. Several rec-
ommendations for preventive health care in adults
with Down syndrome have been published in the
medical literature with varying levels of consensus
(Chicoine and Mcguire 2010; Rubin & Crocker
1989; Pueschel et al. 1995; Cohen 1999; Saenz 1999;
Van Allen et al. 1999; Tyler & Edman 2004; Wilson
& Cooley 2006; Henderson et al. 2007; Virji-Babul
et al. 2007; NewYork Commissioner’s Task Force
2009; Bull & the Committee on Genetics 2011; Ste-
ingass et al. 2011). However, few studies exist that
evaluate adherence to these guidelines (Fergeson
et al. 2009; Maatta et al. 2011; McGrath et al. 2011).
Within paediatric populations, persons with Down
syndrome are significantly less likely to have a
medical home despite higher unmet medical needs
(McGrath et al. 2011). These discrepancies in care
are likely to increase with age (McCabe et al. 2011)
and are especially concerning given that persons
with the number and type of comorbid conditions
as adults with Down syndrome have less capacity to
deal with a new physiological ‘hit’ than many of
their unaffected age-matched peers.
The purpose of this study is to evaluate how
successful primary care physicians in an academic
medical centre were in providing age-, gender-,
and Down syndrome-specific preventive care over
an 8-year period in a cohort of adults with Down
syndrome. Based on our experiences as clinicians
at this institution, we hypothesised that primary
care services were lacking for adults with Down
syndrome. We also hypothesised that there would
not be appreciable differences in preventive
screening patterns based on the field of primary
care.
Methods
Study cohort
Our cohort was identified from administrative data
gathered from our university hospital’s Central
Data Repository, which captures all outpatient,
inpatient, and emergency care within our health
system. Patients aged 18–45 years were included in
the initial cohort if they were seen at our institu-
tion at any time between 1 January 2000 and 30
June 2008 with Down syndrome listed within
any of the 15 diagnostic fields available for each
encounter (n = 252) [International Classification of
Diseases, Ninth Revision, Clinical Modification (ICD-
9-CM) code 758.0] (Bryon & Madge 2001). Diag-
nosis of Down syndrome was then confirmed
through manual chart review utilising a search
engine for free-text documents within the elec-
tronic medical record known as the Electronic
Medical Record Search Engine (EMERSE)
(Hanauer 2006; Hanauer et al. 2009). Search
terms included the following: ‘Down syndrome’,
‘Down’s syndrome’, ‘Downs syndrome’, ‘Trisomy
21’, ‘Tri21’ and ‘Tri 21’. This resulted in 53 cases
without Down syndrome being excluded from our
cohort.
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Within the Central Data Repository, we then
identified all patients (meeting the aforementioned
age and date criteria) who had visits coded for the
commonly associated Down syndrome comorbidi-
ties of congenital heart disease, hypothyroidism, and
atlanto-axial instability. Congenital heart disease
was identified using ICD-9-CM codes 745–745.9,
746–746.9, 747–747.49. Patients with hypothyroid-
ism were identified using ICD-9-CM codes 243,
244.3, 244.8, 244.9. Atlanto-axial instability was
identified with ICD-9-CM code 847.0. EMERSE
(Hanauer 2006; Hanauer et al. 2009) was utilised to
identify patients with documented Down syndrome
in the electronic medical record with one of the
aforementioned comorbidities who had not been
previously identified by ICD-9-CM code 758.0
(n = 29). Only patients with documented Down
syndrome, verified by the authors upon review of
the clinical record, were included in the cohort
(n = 228) (Fig. 1). Through chart review, we then
identified which patients in our cohort received
primary care services within our institution (n = 73).
Patients were assigned to mutually exclusive pro-
vider groups based on the specialty of their primary
care providers (e.g. Family Medicine, Internal
Medicine, Pediatrics, or Internal Medicine-
Pediatrics). Only provider groups with 20 patients
were included in analysis, which led to the exclu-
sion of the Pediatric and Internal Medicine-
Pediatrics provider groups for a final cohort of 62
patients. The Institutional Review Board in our
health system approved the study protocol.
Assessment preventive healthcare domains
Through review of existing preventive healthcare
guidelines for adults with Down syndrome within
the medical literature, areas of broad consensus for
preventive screening were determined to be age-
and gender-appropriate health care in addition to
regular screening for hypothyroidism, obesity,
behavioural, psychiatric or intellectual changes, the
development of cardiac valve, vision, dental, or
hearing abnormalities, and musculoskeletal changes
(Chicoine and Mcguire 2010; Goldhaber et al. 1986,
1987; Pueschel & Scola 1987; Rubin & Crocker
1989; Cooley & Graham 1991; Stebbens et al. 1991;
Yeates 1991; Carey 1992; Geggel et al. 1993; Ameri-
can Academy of Pediatrics 1994, 2001; Pueschel
et al. 1995; Verma et al. 1996; Cohen 1999; Saenz
1999; Van Allen et al. 1999; Feingold & Geggel
2001; Smith 2001; Van Riper & Cohen 2001;
Roizen 2002; Bosch 2003; Tyler & Edman 2004;
Murphy et al. 2005; Wilson & Cooley 2006; Hend-
erson et al. 2007; Virji-Babul et al. 2007; Baum et al.
2008; Davidson 2008; Fergeson et al. 2009; New
York Commissioner’s Task Force 2009; Bull & the
Committee on Genetics 2011; Rimmer et al. 2011;
Steingass et al. 2011). Therefore, the following
screening domains were chosen for evaluation
within our study population: atlanto-axial instability,
cardiac abnormalities, dental abnormalities, hearing
abnormalities, hypothyroidism, obesity, obstructive
sleep apnea, reproductive health care, vision, and a
combined measure evaluating psychiatric disorders,
behaviour difficulties, or memory regression. Crite-
ria for each of these domains are defined in Table 1.
EMERSE was utilised to identify whether patients
had received preventive healthcare screening within
these domains at any time prior to the end of the
8.5-year study. Manual chart review was used to
identify any missing information and to settle any
discrepancies identified within the findings from
EMERSE. Data collection was performed by inves-
tigators KMJ and LCT. The investigators cross-
checked 10% of each other’s data abstraction and
settled any discrepancies by group consensus
through duplicated manual chart review.
Determination of additional variables
The length of time spent in the study cohort was
calculated by the number of years each patient was
within the ages of 18–45 years during the study
time frame (1 January 2000–30 June 2008).Where
applicable, the time period was adjusted for date
of death. Annualised encounters were calculated
through division of their total respective sums by
the number of years each patient was in the study.
Because of inconsistent documentation of medical
insurance for patients in this dataset, insurance
source was not included as a variable in this analy-
sis. Complexity levels of congenital heart disease
were determined through manual chart review, and
were classified as mild, moderate or severe based on
criteria published by the American College of Car-
diology (Warnes et al. 2001).
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Assessed for eligibility (n=108,216) 
All patients aged 18-45years seen in this health system 1 January 2000-
30 June 2008 with chronic and serious illnesses originating in 
childhood. 
Patients with visits coded for Down syndrome (n=252). 
Excluded (n=53) 
No evidence of Down syndrome 
upon review of electronic 
medical record. 
Review of medical records (n=14,774) 
All patients within study frame with visits coded for congenital heart 
disease, hypothyroidism, or atlanto-axial instability. 
Included (n=29) 
Patients with Down syndrome 
documented in medical record 
without a visit coded during 
study frame. 
Final cohort of adults with  Down syndrome receiving  
primary care within this health system (n=62). 
Excluded (n=12) 
Analysis restricted to provider 
groups with ≥20 patients. 
Excluded (n=154) 
All patients who did not receive 
primary care services through 
this health system. 
Total number of adults with Down syndrome receiving  
primary care within this health system (n=74). 
Categorised patients into mutually exclusive provider groups  
based on specialty of primary care provider: 
Family Practice (n=25) 
Internal Medicine (n=37) 
Pediatrics (n=4) 
Internal Medicine-Pediatrics (n=8) 
Total number of adults with Down syndrome within health system (n=228).
Figure 1 Study cohort identification.
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Data analysis
Bivariate comparisons of utilisation patterns and
patient attributes between provider groups were
conducted using chi-squared, Kruskal–Wallis and
t-tests. Stata version 11.1 software (Stata Corp,
College Station,TX, USA) was used for all
analyses.
Results
Sample characteristics
We identified a total of 62 adults with Down syn-
drome, aged 18–45 years, who received primary care
services at our institution at any time between 1
January 2000 and 30 June 2008. This constituted
Table 1 Criteria for screening of preventive healthcare domains
Preventive healthcare
domain
Definition of meeting
diagnostic criteria for given
medical condition
Definition of achieving screening criteria (1 area
within each domain at least once during study
period)
Atlanto-axial instability Documented atlanto-axial
instability in the medical
record or in radiographic
results
Documented atlanto-axial instability
Cervical Spine X-ray, CT, or MRI
Cardiac abnormality Documented congenital heart
disease or other cardiac
abnormalities in the
medical record or in
echocardiographic results
Diagnosis of congenital heart disease or other cardiac
abnormalities
Formal cardiology screening (echocardiogram or EKG)
Referral for cardiology evaluation
Dental care Documented poor dentition in
the medical record
Documented formal dental evaluation
Referral for dental evaluation
Discussion of dentition within the medical record
Hearing loss Documented hearing
abnormalities in medical
record or results from formal
audiology evaluation
Documented formal audiology assessment
Referral for audiology assessment
Discussion of hearing capacity within the medical record
Hypothyroidism Documented hypothyroidism in
the medical record
Documented hypothyroidism
Screening thyroid stimulating hormone or free T4
Overweight/obesity BMI 25 Documented Body Mass Index
Documented diagnosis of obesity/overweightDocumented overweight/obesity
in the medical record Discussion of weight-related concerns within the medical
record
Obstructive sleep apnea Documented obstructive sleep
apnea in the medical record
or in results from formal
sleep evaluation
Documented diagnosis of obstructive sleep apnea
Documented formal sleep study
Referral for sleep study
Discussion of apnea risks within the medical record
Reproductive health care Screening measure only, so no
diagnosis formally tracked
Documented Pap smear/pelvic or testicular examination
Discussion of sexual activity
Prescription of contraception method
Discussion of risk factors for sexually transmitted infections
Screening and treatment for sexually transmitted infections
Psychiatric disorder,
behaviour difficulties,
or memory regression
(combined measure)
Documented intellectual
disability, behaviour problems,
psychiatric condition, memory
loss/regression, or dementia
in the medical record
Documented intellectual disability, behaviour problems,
psychiatric condition, memory loss/regression, or dementia
Discussion of cognition or behaviour within the medical
record
Vision abnormalities* Documented vision
abnormalities in the medical
record
Documented ophthalmological evaluation
Referral for ophthalmological evaluation
Discussion of vision within the medical record
* Ophthalmological care provided on handwritten notes that are not visible within the electronic medical record of this health system.
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372 years of patient data. Members of this cohort
were predominantly male (63%) with a median age
at index encounter of 33 years (Table 2). Only 34%
of our cohort were ever hospitalised during the
study period; of those hospitalised, less than half
had more than one inpatient stay (Fig. 2). There
were five deaths during the study period, causes not
available in the electronic medical record. Nearly all
persons in our cohort required some form of sub-
specialty care, with the median patient accessing
two subspecialty providers. Comorbidities were
common, the most frequent of which were
overweight/obesity (71%), diagnosis of psychiatric
disorders, behaviour difficulties or memory regres-
sion (52%), poor dentition (55%), and hypothyroid-
ism (45%) (Table 3).
Figure 2 Hospitalisation patterns by
provider group.
Table 2 Patient characteristics by provider group
Characteristics (%) Total
Internal
Medicine
Family
Medicine P value
n 62 37(60%) 25 (40%) –
Gender
Female 23 (37%) 11 (30%) 12 (48%) 0.14
Self-reported race/ethnicity
Caucasian 53 (86%) 31 (84%) 22 (88%) 0.64
African American 5 (8%) 2 (5%) 3 (12%) 0.35
Hispanic 0 0 0 –
Asian 0 0 0 –
Other/unknown 4 (7%) 4 (11%) 0 0.09
Median age at index encounter (IQR) 33 years (23–39) 34 years (25–39) 28 years (22–37) 0.38
Mortality during study years 13 (6%) 8 (8%) 5 (5%) 0.32
Median number of specialty providers (IQR) 2 (1–3) 2 (1–4) 2 (1–3) 0.86
Number of patients ever hospitalised during study period 21 (34%) 10 (16%) 11 (18%) 0.17
Median annualised hospitalisations (IQR) 0 (0–0.13) 0 (0–0.13) 0 (0.014) 0.41
Median annualised total visits (IQR) 3.9 (2.1–6.2) 4.2 (2–6.8) 3.7 (2.8–5.9) 0.72
IQR, interquartile range.
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Provider group characteristics
Forty per cent of patients in our cohort received
primary care from Family Medicine practitioners,
with 60% seen in Internal Medicine clinics. No dif-
ferences in demographics were observed between
provider groups, including age, gender, ethnicity or
mortality (Table 3). The Internal Medicine and
Family Medicine provider groups also displayed
similar overall patterns of healthcare utilisation and
hospitalisation. Direct comparison of comorbidities
between provider groups shows similar prevalence
of all conditions evaluated (Table 3), as well as the
presence and severity of congenital heart disease
(Table 4).
Adherence to screening recommendations
Screening patterns for preventive healthcare
domains in adults with Down syndrome were
largely similar between the Internal Medicine and
Family Medicine provider groups (Table 5). Both
provider types achieved high levels of adherence in
screening for obesity and hypothyroidism (>90% in
both domains). Screening was ‘moderate’ (50–80%
adherence) for cardiac anomalies, reproductive
health care, poor dentition, and the combined
measure of behavioural, psychological, or memory
abnormalities. The only areas of discrepancy
between provider groups were in reproductive
health care (adherence = Family Medicine 72%,
Table 3 Presence of comorbidities by provider group
Diagnosis Total (%), n = 62
Internal Medicine
(%), n = 37
Family Medicine
(%), n = 25 P value
Atlanto-axial instability 5 (8) 3 (8) 2 (8) 0.99
Cardiac abnormalities 10 (16) 7 (19) 3 (12) 0.47
Poor dentition 34 (55) 22 (59) 12 (48) 0.42
Hearing loss 17 (27) 9 (24) 8 (32) 0.46
Hypothyroidism 28 (45) 15 (41) 13 (52) 0.37
Overweight/obesity 44 (71) 26 (70) 18 (72) 0.71
Obstructive sleep apnea 15 (24) 11 (30) 4 (16) 0.14
(Combined measure) Psychiatric
disorders, behaviour
difficulties, or
memory regression
32 (52) 14 (46) 15 (60) 0.19
Vision abnormalities 15 (24) 10 (27) 5 (20) 0.55
Table 4 Congenital heart disease complexity by provider group
Complexity of congenital
heart disease Total (%), n = 62
Internal Medicine
(%), n = 37
Family Medicine
(%), n = 25 P value
None 52 (84) 30 (81) 22 (88) 0.47
Mild 2 (3) 1 (3) 1 (4) 0.78
Moderate 3 (5) 2 (5) 1 (4) 0.80
Severe 5 (8) 4 (11) 1 (4) 0.33
Sample diagnoses within each category (Warnes et al. 2001):
• Mild congenital heart disease: isolated patent foramen ovale, isolated small atrial septal defect, isolated small ventricular septal defect
without associated lesions;
• Moderate congenital heart disease: anomalous pulmonary venous return, coarctation of the aorta, Ebstein’s anomaly, Tetralogy of Fallot,
atrioventricular canal defects;
• Severe congenital heart disease: all forms of cyanotic heart disease, double-outlet ventricle, Eisenmenger syndrome, pulmonary atresia,
pulmonary vascular obstructive disease.
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Internal Medicine 43%, P = 0.03) and in screening
for cardiac anomalies (adherence = Internal Medi-
cine 81%, Family Medicine 48%, P = 0.006). Both
provider groups demonstrated low adherence
(<50%) in screening for obstructive sleep apnea,
atlanto-axial instability, hearing loss, and vision
abnormalities.
Discussion
As we approached this study, we hypothesised that
primary care services at our institution would be
insufficient for adults with Down syndrome and
that no substantive differences would be observed
between primary care provider types. Our findings
support these hypotheses. Although few differences
were observed in screening behaviours between pro-
viders in Internal Medicine and Family Medicine at
our institution, it is important to note that overall
adherence to existing preventive healthcare recom-
mendations for adults with Down syndrome was
inconsistent.
Our providers excelled at screening for obesity
and hypothyroidism but demonstrated varying levels
of adherence to the remaining preventive care
domains. Given that screening needed to occur only
once during this 8.5-year study period for patients
to receive credit for any given domain, this is espe-
cially concerning. Nationally, screening patterns for
similar domains in general adult populations dem-
onstrate annual adherence anywhere from 33% for
depression screening (Tudiver et al. 2010) to 92%
for cervical cancer screening (Hughes et al. 2010).
In comparison, 52% of our cohort was screened for
the combined measure of psychiatric disorders,
behavioural disorders or memory regression, and
only 55% of our cohort received reproductive health
screening at least once over this 8.5-year study.
The purpose of primary care is to identify condi-
tions for which prevention, early identification, and
treatment can decrease an individual’s morbidity
and mortality (Robertson et al. 2011). For each of
the preventive healthcare domains addressed in this
study, early detection and intervention have the
potential to make a substantive impact on the lives
of persons with Down syndrome. For example, indi-
viduals with Down syndrome are at high risk for
obesity because of multiple factors, including inac-
tivity and hypothyroidism (Smith 2001; Henderson
et al. 2007; Bull & the Committee on Genetics
2011; Steingass et al. 2011). However, they are also
at high risk for obstructive sleep apnea independent
of obesity, which itself is a known risk factor for
obstructive sleep apnea. Interventions that decrease
obesity, therefore, can have multiple positive down-
stream effects. Additionally, poor dentition has been
identified as risk factor for increased morbidity
(Garcia et al. 1998), while untreated hearing loss
can manifest itself in decreased learning potential,
social withdrawal or even clinical depression
Table 5 Documented preventive screening domains by provider group
Diagnosis Total (%), n = 62
Internal Medicine
(%), n = 37
Family Medicine
(%), n = 25 P value
Atlanto-axial instability 26 (42) 16 (43) 10 (40) 0.8
Cardiac abnormalities 42 (68) 30 (81) 12 (48) 0.006
Dental care 35 (56) 23 (62) 12 (48) 0.27
Hearing loss 29 (47) 18 (49) 11 (44) 0.72
Hypothyroidism 59 (95) 34 (92) 25 (100) 0.14
Overweight/obesity 61 (98) 36 (97) 25 (100) 0.41
Obstructive sleep apnea 22 (35) 13 (35) 9 (36) 0.94
Reproductive health care 34 (55) 16 (43) 18 (72) 0.03
(Combined measure)
Psychiatric disorders,
behaviour difficulties, or
memory regression
32 (52) 17 (46) 15 (60) 0.28
Vision abnormalities 24 (39) 14 (38) 10 (40) 0.86
416
Journal of Intellectual Disability Research volume 57 part 5 may 2013
K. M. Jensen et al. • Primary care for adults with Down syndrome
© 2012The Authors. Journal of Intellectual Disability Research © 2012 Blackwell Publishing Ltd
(Meuwese-Jongejeugd et al. 2006; Hild et al. 2008).
Recently published work in the geriatric (non-Down
syndrome) population indicates that changes in cog-
nitive ability can function as an independent risk
factor for mortality (Sachs et al. 2011). Given the
accelerated ageing and early senescence experienced
by individuals with Down syndrome (Rubin &
Crocker 1989; Pueschel et al. 1995; Smith 2001;
Bittles et al. 2007; NewYork Commissioner’s Task
Force 2009), we anticipate these findings would
readily translate into our population that already
has a baseline level of ID (Singer & Strauss 1997).
In addition to screening for Down syndrome-
specific comorbidities, it is important to ensure
both age- and gender-appropriate screening. This
includes typical primary care domains such as
reproductive health screening, diet, exercise, and
primary prevention of general adult conditions,
such as cardiovascular disease (Bittles et al. 2007).
The invasive nature of some screening mechanisms
must be weighed against each person’s ability to
undergo such procedures. Nonetheless, these con-
versations need to occur between providers, patients
and their caregivers. Informed decisions need to
be made regarding whether traditional screening
methods can be utilised or whether alternative, less
invasive procedures may be used to approximate
care that might not otherwise have been provided
(e.g. fingertip pelvic examination versus traditional
speculum examination) (Kavoussi et al. 2009). Pro-
viders should also weigh the potential benefit of
screening practices with their anticipated interven-
tions should the procedure uncover new medical
issues. In some situations, it is quite reasonable to
forego invasive procedures if the outcome would
not change a patient’s decisions or a clinician’s
behaviour. However, given the rising life expectancy
of persons with Down syndrome, it is inappropriate
to ignore age- and gender-appropriate care simply
because of the presence of ID.
When compared with national estimated preva-
lence rates of comorbidities in adults with Down
syndrome (Rubin & Crocker 1989; Cooley &
Graham 1991; Bell & Bhate 1992; Prasher 1995;
Pueschel et al. 1995; American Academy of Pediat-
rics 2001; Melville et al. 2005; NewYork Commis-
sioner’s Task Force 2009; Steingass et al. 2011), the
individuals observed in this cohort appear to be
slightly less complex on average. Our medical
records indicate lower prevalence of several condi-
tions in our cohort, with the exception of hypothy-
roidism, overweight/obesity and the combined
measure of psychiatric disorders, behaviour difficul-
ties, or memory regression (Fig. 3).We hypothesise
that these numbers may be artificially underesti-
mated, as prevalence estimates in our cohort are
completely dependent upon what has been docu-
mented in the medical record and not prospective
evaluation.We suspect the lower numbers of
persons identified with obstructive sleep apnea
reflect less screening performed at our institution
than is done on a national level. Additionally, care
by dentists and ophthalmologists is often docu-
mented in paper charts within our health system,
which were not available for review by the investiga-
tors of this study.
Limitations
This study has several limitations. First, our work
reflects the experiences of patients with Down syn-
drome at a single tertiary care centre with multiple
associated primary care clinics. This may not reflect
trends in primary care practices that would be
evident on a national level.
Second, the small population of patients in each
of the primary care practices, especially in Internal
Medicine-Pediatrics and Pediatrics, may prevent
observation of true differences in care practices that
would be evident within a larger cohort. However,
despite the fact that the overall number of patients
described in this study is not particularly large, this
cohort of adults with Down syndrome is compa-
rable in size to many previously described in the
medical literature.
Third, documentation of receipt of screening
domains was limited to what was recorded in the
electronic medical records. This likely underesti-
mated the domains of ophthalmology, dentistry,
audiology and psychiatry, as these fields often store
clinical charts outside of the electronic medical
record typically utilised within this health system.
Additionally, the scope of this study is to evaluate
the presence or absence of screening behaviours
and does not follow any subsequent interventions
on the part of clinicians.
These limitations notwithstanding, we expect that
the experience of caring for adults with Down syn-
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drome at our institution will serve as a reasonable
approximation of primary care clinicians nationally.
If anything, we would anticipate that the proximity
to subspecialty care might artificially increase
adherence rates to screening recommendations.
Given the overall low adherence to preventive care
recommendations observed in this study, this does
not appear to be a concern.
Conclusion
Despite well-published recommendations for pre-
ventive health care in adults with Down syndrome,
little is known about adherence to these guidelines.
Our findings represent one of the first comparisons
of primary care practices in a cohort of adults with
Down syndrome.
We observed that adherence to existing preventive
care guidelines was inconsistent but did not result
from the ‘type’ of primary care each patient
received (Family Medicine vs. Internal Medicine).
Rather, the patterns of incomplete adherence to
Down syndrome-specific guidelines appear to
mirror the discomfort in providing care for adults
with ID observed in adult-oriented clinicians previ-
ously documented in the medical literature
(Okumura et al. 2010; Pace et al. 2011).
The reasons behind the inconsistent screening
patterns observed in this study may serve as a
reflection of several possibilities: poor documenta-
tion of issues discussed during a clinic visit, lack of
awareness by the provider of existing recommenda-
tions, or more urgent medical concerns that super-
sede primary care discussions. In light of such
findings, it is important to remember that improved
screening has the potential to identify issues that
can be readily treated and lead to decreased mor-
bidity and mortality. This will allow patients and
families to make more informed decisions about
their care. To achieve improvements, preventive
healthcare recommendations need to be widely dis-
seminated and readily available to all primary care
providers.
Figure 3 Prevalence of comorbidities in adults with Down syndrome. * National prevalence estimates taken from: Rubin & Crocker 1989;
Cooley & Graham 1991; Bell & Bhate 1992; Prasher 1995; American Academy of Pediatrics 2001; Melville et al. 2005; NewYork
Commissioner’s Task Force 2009; Steingass et al. 2011.
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We hypothesise that the number and varying
scope of existing preventive care recommendations
for adults with Down syndrome has made it diffi-
cult for clinicians to implement many of these
screening guidelines and adds confusion to already
complex care management.We highlight the recom-
mendations from the American Academy of Pediat-
rics (Bull & the Committee on Genetics 2011) and
Steingass et al. (2011) as the most recently pub-
lished high quality references for primary care phy-
sicians, and we encourage greater collaboration
between stakeholders within the Down syndrome
community to regularly disseminate recommenda-
tions incorporating expert opinion with evidence-
based medicine. As a medical community, we need
to place greater emphasis on improving the collec-
tion and storage of high-quality longitudinal data to
better inform clinical guidelines. Further studies are
needed to assess the implications of current screen-
ing recommendations and more timely identifica-
tion of comorbidities on clinical outcomes.
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